Chemical Compound
L-Lyxonamide, 2,4,5-trideoxy-4-((3,3-dimethyl-2-((((1-methyl-1H-tetrazol-5-yl)thio)acetyl)amino)-1-oxobutyl)amino)-N-(1-((((2-hydroxy-4-methoxyphenyl)methyl)amino)carbonyl)-2-methylpropyl)-2-(((4-methoxyphenyl)methyl)amino)-5-phenyl-, (1(S),4(S))-
CAS Registry Number
169305-69-5
Primary record
L-Lyxonamide, 2,4,5-trideoxy-4-((3,3-dimethyl-2-((((1-methyl-1H-tetrazol-5-yl)thio)acetyl)amino)-1-oxobutyl)amino)-N-(1-((((2-hydroxy-4-methoxyphenyl)methyl)amino)carbonyl)-2-methylpropyl)-2-(((4-methoxyphenyl)methyl)amino)-5-phenyl-, (1(S),4(S))-
- 库存
- 6,035 克
- 纯度
- 99.4 %
- CAS
- 169305-69-5
化合物标识与属性
- CAS
- 169305-69-5
- PubChem CID
- 462233
- SMILES
- CC(C)[C@@H](C(=O)NCC1=C(C=C(C=C1)OC)O)NC(=O)[C@@H]([C@@H]([C@H](CC2=CC=CC=C2)NC(=O)[C@H](C(C)(C)C)NC(=O)CSC3=NN=NN3C)O)NCC4=CC=C(C=C4)OC
- Canonical SMILES
- COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2ccc(OC)cc2O)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CSc2nnnn2C)C(C)(C)C)cc1
名称与同义词
- AC1LA5OU
- Cbz-Val-NHPhCH2-Statine deriv.
- DTXSID00168699
- FXCOLMDDHSTZIY-RCNBIBPKSA-N
- AIDS031496
- CID462233
- 169305-69-5
- J693.799C
- (2S)-N-[(2S,3R,4R)-3-hydroxy-5-[[(2S)-1-[(2-hydroxy-4-methoxyphenyl)methylamino]-3-methyl-1-oxobutan-2-yl]amino]-4-[(4-methoxyphenyl)methylamino]-5-oxo-1-phenylpentan-2-yl]-3,3-dimethyl-2-[[2-(1-methyltetrazol-5-yl)sulfanylacetyl]amino]butanamide
- L-Lyxonamide, 2,4,5-trideoxy-4-((3,3-dimethyl-2-((((1-methyl-1H-tetrazol-5-yl)thio)acetyl)amino)-1-oxobutyl)amino)-N-(1-((((2-hydroxy-4-methoxyphenyl)methyl)amino)carbonyl)-2-methylpropyl)-2-(((4-methoxyphenyl)methyl)amino)-5-phenyl-, (1(S),4(S))-
- (2R,3S,4S)-N-(4-(3-hydroxy-2-(4-methoxybenzylamino)((N-((1-methyl-1,3,4,5-tetrazol-2-thiaocetyl)tert.leucinyl)amino)-5-phenylpentanoyl)valine 2-hydroxy-4-methoxy-benzylamide
- (2R,3R,4S)-4-[(2S)-3,3-dimethyl-2-{2-[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]acetamido}butanamido]-3-hydroxy-N-[(1S)-1-{[(2-hydroxy-4-methoxyphenyl)methyl]carbamoyl}-2-methylpropyl]-2-{[(4-methoxyphenyl)methyl]amino}-5-phenylpentanamide
- (2R,3R,4S)-4-[(2S)-3,3-Dimethyl-2-{2-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]acetamido}butanamido]-3-hydroxy-N-[(2S)-1-{[(2-hydroxy-4-methoxyphenyl)methyl]amino}-3-methyl-1-oxobutan-2-yl]-2-{[(4-methoxyphenyl)methyl]amino}-5-phenylpentanamide
- (2R,3S,4S)-N-[4-[3-hydroxy-2-(4-methoxybenzylamino)[[N-[(1-methyl-1,3,4,5-tetrazol-2-thiaocetyl)tert.leucinyl]amino]-5-phenylpentanoyl]valine 2-hydroxy-4-methoxy-benzylamide
- (2S)-N-[(1S,2R,3R)-1-benzyl-2-hydroxy-4-[[(1S)-1-[(2-hydroxy-4-methoxy-phenyl)methylcarbamoyl]-2-methyl-propyl]amino]-3-[(4-methoxyphenyl)methylamino]-4-oxo-butyl]-3,3-dimethyl-2-[[2-(1-methyltetrazol-5-yl)sulfanylacetyl]amino]butanamide
- L-Lyxonamide, 2,4,5-trideoxy-4-[[3,3-dimethyl-2-[[[(1-methyl-1H-tetrazol-5-yl)thio]acetyl]amino]-1-oxobutyl]amino]-N-[1-[[[(2-hydroxy-4-methoxyphenyl)methyl]amino]carbonyl]-2-methylpropyl]-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-, [1(S),4(S)]-
- N-[[(1-Methyl-1H-tetrazol-5-yl)thio]acetyl]-3-methyl-L-Val-[(3R,4S)-N2-(4-methoxybenzyl)-3-hydroxy-4-benzyl-D-A2bu*-]-L-Val-(2-hydroxy-4-methoxybenzyl)NH2